Skip to main content
KROMEK GROUP PLC logo

KROMEK GROUP PLC — Investor Relations & Filings

Ticker · KMK ISIN · GB00BD7V5D43 LEI · 213800VLHYXGHEX5VQ48 IL Manufacturing
Open in API
Filings indexed 351 across all filing types
Latest filing 2023-04-19 Regulatory Filings
Country GB United Kingdom
Listing IL KMK

About KROMEK GROUP PLC

https://www.kromek.com/

Kromek Group plc is a developer and manufacturer of advanced radiation detection solutions based on high-performance sensor materials, primarily Cadmium Zinc Telluride (CZT) and scintillation detectors. The company provides hardware, software, and components to original equipment manufacturers (OEMs) and end-users across the advanced imaging, civil nuclear, and security markets. Key applications include medical imaging systems (such as SPECT and photon-counting CT), industrial inspection, and CBRN (Chemical, Biological, Radiological, Nuclear) threat detection for homeland security, military, and civil nuclear sectors. The company's proprietary CZT manufacturing process enables the production of high-resolution, room-temperature semiconductor detectors that offer enhanced sensitivity and performance for imaging and radionuclide identification.

Recent filings

Filing Released Lang Actions
Kromek and Analogic Collaboration Agreement
Regulatory Filings Classification · 98% confidence The document is identified by the RNS Number header and the closing statement indicating it is provided by RNS, the news service of the London Stock Exchange. The content announces a 'Collaboration Agreement' between Kromek Group PLC and Analogic Corporation regarding technology development. This type of announcement, which is a material corporate event but not a formal financial report (like 10-K or IR) or a specific transaction (like DIV or POS), typically falls under general regulatory announcements. Since it is a formal announcement distributed via the RNS system, and it doesn't fit the specific categories like M&A (TAR), Capital Change (CAP/SHA), or Director Dealing (DIRS), the most appropriate classification is the general regulatory filing category.
2023-04-19 English
Trading Update
Earnings Release Classification · 100% confidence The document is identified by the RNS Number (5101W) and the closing statement explicitly mentioning 'This information is provided by RNS, the news service of the London Stock Exchange.' This indicates it is a regulatory announcement. The content provides a 'Trading Update' detailing Q3 performance, revenue expectations for FY 2023, gross margin outlook, and EBITDA expectations for H2 2023. This is a summary of recent performance, not a full comprehensive report (like 10-K or IR). Since it is a brief, periodic update released via the RNS system, it fits best under the 'Earnings Release' (ER) category, which covers initial announcements of periodical financial results (key highlights only). It is too specific for the general 'RNS' fallback, and it is not an announcement *about* a report (RPA), but the update itself. Q3 2023
2023-04-18 English
Seven-Year Agreement with Tier 1 OEM
M&A Activity Classification · 99% confidence The document starts with an 'RNS Number' and is dated April 18, 2023. The content announces a significant business event: a 'Seven-Year Agreement with Tier 1 OEM' for detector supply and development. This is a material, non-periodic announcement made via the Regulatory News Service (RNS) system, which is explicitly mentioned at the end of the document, stating: "This information is provided by RNS, the news service of the London Stock Exchange." Since this is a general regulatory announcement that doesn't fit the specific categories like Director's Dealing (DIRS), Dividend Notice (DIV), or Earnings Release (ER), the most appropriate classification is the general regulatory filing category.
2023-04-18 English
Kromek secures orders totalling over $1m
Regulatory Filings Classification · 98% confidence The document begins with 'RNS Number : 5402U' and contains standard boilerplate language associated with regulatory news service announcements from the London Stock Exchange (LSE). The content announces that the company 'has secured repeat orders totaling over $1m in medical imaging.' This is a specific, material business update that is not a full financial report (like 10-K or IR), a management change (MANG), or a dividend announcement (DIV). It is a general announcement of a business development/contract win. Since it is a formal announcement distributed via RNS and doesn't fit the more specific categories like ER (Earnings Release) or CAP (Capital/Financing Update), the most appropriate classification is the general regulatory announcement category, RNS.
2023-03-29 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is explicitly labeled with 'RNS Number' and contains a 'TR-1: Standard form for notification of major holdings'. This form details changes in voting rights and share ownership by an individual (David and Monique Newlands) in Kromek Group PLC, crossing a notification threshold. This type of filing, reporting changes in significant shareholdings, directly corresponds to the Major Shareholding Notification category. Although it is distributed via RNS, the specific content dictates the classification over the general RNS fallback.
2023-03-22 English
Kromek awarded c. £2.5m by Innovate UK
Regulatory Filings Classification · 99% confidence The document begins with an 'RNS Number' and is dated January 31, 2023. It announces that 'Kromek Group PLC' has been awarded funding for breast cancer screening solution developments. The content is a press release detailing a business development, funding award, and technological progress, rather than a formal financial report (like 10-K or IR) or a meeting material (like AGM-R or DEF 14A). The presence of the RNS header and footer strongly suggests this is a general regulatory announcement distributed via the London Stock Exchange's news service. Since it is a specific business update that doesn't fit into the other specialized categories (like M&A, Capital Change, or Director Dealing), the most appropriate classification is the general regulatory announcement category, RNS.
2023-01-31 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.